S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Completed · Phase 2
Conditions studied: Multiple Myeloma
In brief
RATIONALE: Thalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplant may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Giving thalidomide before and after peripheral stem cell transplant may be effective in treating newly diagnosed multiple myeloma. PURPOSE: This phase II trial is studying how well giving thalidomide with chemotherapy and peripheral stem cell transplant work in treating patients with newly diagnosed multiple myeloma.
Key facts
- Study ID
- NCT00040937
- Run by
- SWOG Cancer Research Network
- People needed
- 147
- Starts
- 2002-06-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2016-12-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California Davis Cancer Center — Davis, California, United States
- Sutter Roseville Medical Center — Roseville, California, United States
- Sutter Cancer Center — Sacramento, California, United States
- Piedmont Hospital — Atlanta, Georgia, United States
- CCOP - Atlanta Regional — Atlanta, Georgia, United States
- Northside Hospital Cancer Center — Atlanta, Georgia, United States
- Saint Joseph's Hospital of Atlanta — Atlanta, Georgia, United States
- WellStar Cobb Hospital — Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at DeKalb Medical Center — Decatur, Georgia, United States
- Gwinnett Medical Center — Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital — Marietta, Georgia, United States
- Southern Regional Medical Center — Riverdale, Georgia, United States
- Cancer Research Center of Hawaii — Honolula, Hawaii, United States
- OnCare Hawaii, Incorporated - Lusitana — Honolulu, Hawaii, United States
- Queen's Cancer Institute at Queen's Medical Center — Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated — Honolulu, Hawaii, United States
- OnCare Hawaii, Incorporated - Kuakini — Honolulu, Hawaii, United States
- St. Francis Medical Center — Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children — Honolulu, Hawaii, United States
- Kapiolani Medical Center at Pali Momi — ‘Aiea, Hawaii, United States
- St. Luke's Mountain States Tumor Institute - Boise — Boise, Idaho, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
- St. Francis Hospital and Health Centers — Beech Grove, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.